Abstract
Despite the increasingly widespread use of endovascular left atrial appendage occlusion (ELAAO) in the treatment of patients with atrial fibrillation (AF), the choice of optimal tactics for performing the procedure, especially subsequent antithrombotic therapy, remains poorly understood. This review was conducted with the aim of critically assessing current ideas about the safety and effectiveness of ELAAO in AF. The results of the most important clinical studies of ELAAO in patients with AF, the provisions of current clinical recommendations for this procedure are discussed. The available data on the possibilities of antithrombotic therapy after ELAAO and the prospects for future research in filling gaps in the evidence base for this technique are reviewed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Siberian Journal of Clinical and Experimental Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
